New York State Common Retirement Fund
OREX

New York State Common Retirement Fund’s Orexigen Therapeutics, Inc. OREX Stock Holding History

New York State Common Retirement Fund’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9,340
Closed -$40K – 3253
2016
Q2 		$40K Hold
9,340
– – ﹤0.01% 3100
2016
Q1 		$53K Hold
9,340
– – ﹤0.01% 3053
2015
Q4 		$161K Hold
9,340
– – ﹤0.01% 2872
2015
Q3 		$197K Sell
9,340
-5,393
-37% -$185K ﹤0.01% 2795
2015
Q2 		$729K Buy
14,733
+11,403
+342% +$682K ﹤0.01% 2352
2015
Q1 		$261K Buy
+3,330
New +$207K ﹤0.01% 2119

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

New York State Common Retirement Fund's OREX Position: Q3 2016 in Review

New York State Common Retirement Fund sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2016, closing a stake of 9,340 shares — an estimated $40K sold.

New York State Common Retirement Fund first reported a position in OREX in Q1 2015 and held it in 6 quarters. The position peaked at $729K in Q2 2015. 55 funds tracked by Wall St. Rank hold OREX as of Q3 2016.

  • New York State Common Retirement Fund reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • New York State Common Retirement Fund sold 9,340 Orexigen Therapeutics, Inc. shares in Q3 2016, an estimated $40K.
  • New York State Common Retirement Fund first reported a position in Orexigen Therapeutics, Inc. in Q1 2015 and held it in 6 quarters.
  • New York State Common Retirement Fund's Orexigen Therapeutics, Inc. position peaked at $729K in Q2 2015.
  • 55 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2016.

Based on New York State Common Retirement Fund's 13F filing for Q3 2016, filed 8 Nov 2016.